insights_auto
Why is MBIO down 2.44%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
$0.40
arrow_downward
-2.44%(-0.010) 1D
$0.40
arrow_upward
+1.15% (+0.0046)bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
$0.43
High
$0.43
Low
$0.38
Mkt. cap
3.01M
Avg. vol.
29.09K
Volume
99.18K
52-wk high
$1.80
52-wk low
$0.38
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
Open
$0.43
High
$0.43
Low
$0.38
Mkt. cap
3.01M
Avg. vol.
29.09K
Volume
99.18K
52-wk high
$1.80
52-wk low
$0.38
EPS
-$0.46
Beta
2.09
Shares outstanding
6.73M
No. of employees
4
News stories
From web sources and news partners
TradingView
·
59 minutes ago
'AI is all that matters': How 42 artificial intelligence stocks drive 67% of S&P 500 gains since 2024
Finimize
·
56 minutes ago
PM Capital Blamed A Narrow US Rally For Its September Dip
FXLeaders
·
5 hours ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
CryptoRank
·
13 hours ago
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitemustangbio.com